An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III ...

Clascoterone will be the first ever drug in 30 years to treat male pattern baldness by boosting hair growth by 500% ...

A new topical treatment, Clascoterone, shows significant promise for male pattern baldness, offering a novel approach beyond ...

The promising results are expected to fetch the FDA approval next year, which would mean that clascoterone will be the first ...

New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after ...

Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

In two large late-stage clinical trials, the company’s experimental drug clascoterone triggered significant hair regrowth in ...

Male pattern baldness (androgenetic alopecia) is a common issue that can happen to men of all ages. It can cause diffuse hair loss across the entire scalp, a receding hairline, a bald patch, or a mix ...

Hair loss has frustrated millions of men worldwide for decades, with few truly novel treatments emerging beyond minoxidil and oral anti-androgens. But 2025 may mark a turning point. A company-backed ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

Most people experience hair loss because of androgenetic alopecia (pattern baldness), which at least in men, is highly genetic. We know much less about female pattern baldness. Male pattern baldness ...